Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Other Non-Current Assets (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Other Non-Current Assets for 4 consecutive years, with $12815.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets fell 34.87% to $12815.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12815.0 through Dec 2025, down 34.87% year-over-year, with the annual reading at $12815.0 for FY2025, 34.87% down from the prior year.
  • Other Non-Current Assets for Q4 2025 was $12815.0 at bioAffinity Technologies, roughly flat from $12815.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $19676.0 in Q3 2024, with the low at $6000.0 in Q3 2022.
  • Average Other Non-Current Assets over 4 years is $13654.7, with a median of $14437.5 recorded in 2023.
  • The sharpest move saw Other Non-Current Assets soared 184.32% in 2024, then tumbled 34.87% in 2025.
  • Over 4 years, Other Non-Current Assets stood at $6000.0 in 2022, then surged by 167.67% to $16060.0 in 2023, then increased by 22.52% to $19676.0 in 2024, then crashed by 34.87% to $12815.0 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $12815.0, $12815.0, and $12814.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.